Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 16 articles: HTML format

Single Articles

May 2025
1. SCIURBA FC, Criner GJ, Christenson SA, Martinez FJ, et al
   Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
   N Engl J Med. 2025;392:1710-1720.
   PubMed     Abstract available
   
   
   April 2025
2. HILL AT
   Defanging the Neutrophil to Treat Bronchiectasis.
   N Engl J Med. 2025;392:1649-1652.
   PubMed    
   
   
   
3. BELL SC, Grimwood K
   Brensocatib in Bronchiectasis - A New Sheriff in Town?
   N Engl J Med. 2025;392:1647-1648.
   PubMed    
   
   
   
4. CHALMERS JD, Burgel PR, Daley CL, De Soyza A, et al
   Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
   N Engl J Med. 2025;392:1569-1581.
   PubMed     Abstract available
   
   
   March 2025
5. HU X
   Emphysematous Vertebral Osteomyelitis.
   N Engl J Med. 2025;392:1017.
   PubMed    
   
   
   September 2024
6. BHATT SP, Rabe KF, Bafadhel M
   Dupilumab for COPD with Elevated Eosinophil Counts. Reply.
   N Engl J Med. 2024;391:1164.
   PubMed    
   
   
   
7. ROLLA G
   Dupilumab for COPD with Elevated Eosinophil Counts.
   N Engl J Med. 2024;391:1163-1164.
   PubMed    
   
   
   
8. EKSTROM M, Andersson A, Papadopoulos S, Kipper T, et al
   Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia.
   N Engl J Med. 2024;391:977-988.
   PubMed     Abstract available
   
   
   
9. TAICHMAN DB, Drazen JM
   Making Long-Term Oxygen Therapy Less Burdensome.
   N Engl J Med. 2024;391:1050-1051.
   PubMed    
   
   
   
10. AARON SD
    Early Diagnosis and Treatment of COPD and Asthma. Reply.
    N Engl J Med. 2024;391:968.
    PubMed    
    
    
    
11. VAN GEFFEN WH, van der Meer AN
    Early Diagnosis and Treatment of COPD and Asthma.
    N Engl J Med. 2024;391:967-968.
    PubMed    
    
    
    
12. JACKSON DJ, Wechsler ME, Jackson DJ, Bernstein D, et al
    Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.
    N Engl J Med. 2024 Sep 9. doi: 10.1056/NEJMoa2406673.
    PubMed     Abstract available
    
    
    July 2024
13. ASSAD Z, Romain AS, Aupiais C, Shum M, et al
    Nirsevimab and Hospitalization for RSV Bronchiolitis.
    N Engl J Med. 2024;391:144-154.
    PubMed     Abstract available
    
    
    June 2024
14. BHATT SP, Rabe KF, Hanania NA, Vogelmeier CF, et al
    Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
    N Engl J Med. 2024;390:2274-2283.
    PubMed     Abstract available
    
    
    
15. DIAO JA, He Y, Khazanchi R, Nguemeni Tiako MJ, et al
    Implications of Race Adjustment in Lung-Function Equations.
    N Engl J Med. 2024;390:2083-2097.
    PubMed     Abstract available
    
    
    May 2024
16. AARON SD, Vandemheen KL, Whitmore GA, Bergeron C, et al
    Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial.
    N Engl J Med. 2024 May 19. doi: 10.1056/NEJMoa2401389.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.